Nanodiscs: a versatile nanocarrier platform for cancer diagnosis and treatment
J Bariwal, H Ma, GA Altenberg, H Liang - Chemical Society Reviews, 2022 - pubs.rsc.org
Cancer therapy is a significant challenge due to insufficient drug delivery to the cancer cells
and non-selective killing of healthy cells by most chemotherapy agents. Nano-formulations …
and non-selective killing of healthy cells by most chemotherapy agents. Nano-formulations …
[HTML][HTML] Re-establishing the comprehension of phytomedicine and nanomedicine in inflammation-mediated cancer signaling
NK Jha, S Arfin, SK Jha, R Kar, A Dey… - Seminars in Cancer …, 2022 - Elsevier
Recent mounting evidence has revealed extensive genetic heterogeneity within tumors that
drive phenotypic variation affecting key cancer pathways, making cancer treatment …
drive phenotypic variation affecting key cancer pathways, making cancer treatment …
Immune-cell-derived exosomes for cancer therapy
Exosomes are a type of extracellular vesicles secreted by cells in normal or pathological
conditions for cell–cell communication. With immunomodulatory characteristics and potential …
conditions for cell–cell communication. With immunomodulatory characteristics and potential …
Recent advancements in the design of nanodelivery systems of siRNA for cancer therapy
RNA interference (RNAi) has increased the possibility of restoring RNA drug targets for
cancer treatment. Small interfering RNA (siRNA) is a promising therapeutic RNAi tool that …
cancer treatment. Small interfering RNA (siRNA) is a promising therapeutic RNAi tool that …
Effects of curcumin-loaded poly (lactic-co-glycolic acid) nanoparticles in MDA-MB231 human breast cancer cells
Aim: This study was aimed at evaluating the anticancer potential of curcumin-loaded poly
(lactic-co-glycolic acid)(PLGA) based nanoparticles (NPs) in MDA-MB231 human breast …
(lactic-co-glycolic acid)(PLGA) based nanoparticles (NPs) in MDA-MB231 human breast …
[HTML][HTML] Nanocarriers for delivery of siRNA as gene silencing mediator
A Morales-Becerril, L Aranda-Lara, K Isaac-Olivé… - EXCLI …, 2022 - ncbi.nlm.nih.gov
The term nanocarrier refers to sub-micrometric particles of less than 100 nm, designed to
transport, distribute, and release nanotechnology-based drug delivery systems. siRNA …
transport, distribute, and release nanotechnology-based drug delivery systems. siRNA …
Emerging potential of exosomal non-coding RNA in parkinson's disease: a review
Exosomes are extracellular vesicles that are released by cells and circulate freely in body
fluids. Under physiological and pathological conditions, they serve as cargo for various …
fluids. Under physiological and pathological conditions, they serve as cargo for various …
Chitosan nanocarriers for non-coding RNA therapeutics: A review
S Karthik, S Mohan, I Magesh, A Bharathy… - International Journal of …, 2024 - Elsevier
Abstract Non-coding RNA (ncRNA)-based therapies entail delivering ncRNAs to cells to
regulate gene expression and produce proteins that combat infections, cancer, neurological …
regulate gene expression and produce proteins that combat infections, cancer, neurological …
Robust Polyion Complex Vesicles (PICsomes) Based on PEO‐b‐poly(amino acid) Copolymers Combining Electrostatic and Hydrophobic Interactions: Formation …
E Aydinlioglu, M Abdelghani, G Le Fer… - Macromolecular …, 2023 - Wiley Online Library
Two pairs of oppositely charged PEO‐b‐poly (amino acid) copolymers with neutral poly
(ethylene oxide) block and polypeptide block composed of the hydrophobic l‐phenylalanine …
(ethylene oxide) block and polypeptide block composed of the hydrophobic l‐phenylalanine …
Development of novel poly-l-lysine-modified sericin-coated superparamagnetic iron oxide nanoparticles as siRNA carrier
Small interfering RNA (siRNA) is a promising therapeutic modality, however, its successful
clinical application is still challenging due to the lack of safe and efficient carrier systems …
clinical application is still challenging due to the lack of safe and efficient carrier systems …